As of June 2026, 43 paid clinical trials are recruiting in Zion, Illinois. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Zion offers studies at sites including Midwestern Regional Medical Center for conditions such as Breast Cancer, Clear Cell Renal Cell Carcinoma, Hematologic Malignancies, Hodgkin Lymphoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Zion has approximately 43 recruiting research studies across a wide range of therapeutic areas. Illinois's research base includes Northwestern Medicine, Rush University Medical Center, University of Chicago Medicine, and Ann & Robert H. Lurie Children's Hospital, covering oncology, cardiology, and pediatric specialties.
Researchers run research studies in Zion, IL at 14 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Midwestern Regional Medical Center | Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Adenocarcinoma of the Colon | 16 |
| City of Hope at Chicago | Advanced Colon Adenocarcinoma, Advanced Colorectal Adenocarcinoma, Advanced Rectal Adenocarcinoma | 6 |
| City of Hope Chicago | Breast Cancer, Metastatic, Carcinoma, Non-Small-Cell Lung, Hodgkin Lymphoma | 4 |
| City of Hope® Cancer Center Chicago | Breast Cancer, KRAS G12C Lung Cancer, Non-Small Cell Lung Cancer | 2 |
| Midwestern Regional Medical Center dba City of Hope Chicago | Metastatic Castration-resistant Prostate Cancer, Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR) | 2 |
| City Of Hope - Chicago | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, Renal Cell | 2 |
| Cancer Treatment Centers of America (CTCA) | Metastatic Non-small Cell Lung Cancer | 1 |
| City of Hope - Cancer Center Chicago | Breast Cancer | 1 |
| City of Hope - Chicago Cancer Center | Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC) | 1 |
| City of Hope Chicago Cancer Center | Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Extragonadal Yolk Sac Tumors, Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer | 1 |
| Midwestern Reg MC COH Chicago | Early Breast Cancer | 1 |
| Midwestern Regional Medical Center, City of Hope Chicago | Locally Advanced Solid Tumor | 1 |
| Midwestern Regional Medical Center, Inc. dba City of Hope Chicago | Multiple Myeloma | 1 |
| NEO-811 Chicago Site | Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic, Kidney Cancer Metastatic | 1 |
Recruiting trials in Zion grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Illinois are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Illinois studies must also comply with the Illinois Personal Information Protection Act (PIPA) and Biometric Information Privacy Act (BIPA) where applicable.
Hipa.ai aggregates every recruiting study in Zion from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 43 recruiting clinical trials in Zion, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Zion compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Zion include Breast Cancer (3), Clear Cell Renal Cell Carcinoma (2), Hematologic Malignancies (2), Hodgkin Lymphoma (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Zion on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Zion include Midwestern Regional Medical Center, City of Hope at Chicago, City of Hope Chicago, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Zion are Cancer & tumors (39). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.